Home > Boards > US OTC > Medical - Drugs >

Dragon Pharma (DRUG)

Add DRUG Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 4/4/2010 2:31:27 PM - Followers: 1 - Board type: Free - Posts Today: 0

Summary Dragon Pharmaceutical Inc. (Dragon) is an international pharmaceutical company. Dragon produces and supplies a line of antibiotic products covering intermediates, active pharmaceutical ingredients and formulation drugs. The Company is a manufacturer and distributor of a broad line of antibiotic products, including 7-ACA, a key intermediate to produce cephalosporin antibiotics, Clavulanic Acid, and formulated cephalosporin antibiotic drugs. Dragon is a 7-ACA producer and a manufacturer of Clavulanic Acid products in China. In April 2008, the Company announced that it has realigned its business segments into two divisions: Cephalosporin and Penicillin. 650 West Georgia Street Suite 310 Vancouver, BC V6B 4N9 Canada +1-604-6698817 (Phone) +1-604-6694243 (Fax) Company website: http://www.dragonpharma.com/ News Releases, Investor Relations, Financial Information, Corporate History/Profile, Executives, Products/Services, Employment Opportunities Officers and directors Yanlin Han > Chairman of the Board, Chief Executive Officer Officer Since: 01/2005 Age: 44 Garry Wong > Chief Financial Officer Officer Since: 01/2005 Age: 36 Maggie Deng > Chief Operating Officer, Secretary Officer Since: 01/2005 Age: 39 Alexander Wick Ph.D. > Director Officer Since: 09/2002 Age: 69 Zhanguo Weng > Director Officer Since: 01/2005 Age: 52 Yiu Kwong Sun M.D. > Director Officer Since: 11/1999 Age: 63 Xuemei Liu > Director Officer Since: 01/2005 Age: 37 Peter Mak > Director Officer Since: 09/30/2005 Age: 46 Heinz Frey > Director Officer Since: 09/30/2005 Age: 69 Dragon Pharmaceutical Inc. (Ticker: OTCBB: DRUG, TSX: DDD, BBSE: DRP) is an international pharmaceutical company incorporated in Florida, United States of America Dragon produces and supplies a broad line of high-quality antibiotic products covering intermediates, active pharmaceutical ingredients and formulation drugs, which all showed significant growth in the past few years Dragon is the third largest manufacturer and the largest exporter of 7ACA in China and supplying 30% of its production to the international market Dragon is the first manufacturer and remains the market leader for Clavulanic Acid with a market share of 80% in China and 30% in India In the full year 2007, total sales revenue was $85.8 million US dollars, representing an increase of 64% from $52.4 million recorded for the full year 2006. Net income from continuing operations reached $4.9 million US dollars for the year of 2007 Dragon's business strategy is to focus on antibiotic product lines, currently on Cephalosporin group and Penicillin group, two of the most important product lines for anti-infective drugs which have been widely used for treatment of various infections and diseases worldwide; Dragon’s product strategy is to integrate product lines from intermediates to Active Pharmaceutical Ingredients (API) to formulated products to maximize market dominating position, while developing new pipelines within the product lines horizontally to leverage the current resources for future growth
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DRUG News: Dragon Pharma shareholders approve merger and seek termination of listing on the OTCBB and TSX 07/20/2010 06:00:00 PM
DRUG News: Dragon Pharma announces receipt of preliminary proxies to approve merger 07/07/2010 06:00:00 PM
DRUG News: Dragon Pharma announces date of special meeting 06/28/2010 06:00:00 PM
DRUG News: Dragon Pharma reports 2010 first quarter financial results 05/17/2010 05:00:00 PM
DRUG News: Complaint Filed Regarding Proposed Merger 04/22/2010 06:00:00 PM
#16   Do you have some DRUGS? Bob Stocks 04/04/10 02:31:27 PM
#15   PRESS RELEASE: Dragon Pharma Reports 2009 Full Year 10 bagger 04/03/10 10:00:11 AM
#14   Well, i guess my shares are gonna be Bob Stocks 03/27/10 02:06:38 PM
#13   What baffles me is how come the pps ChartMasterpieces 02/27/10 06:44:38 PM
#12   I think the company officers (insiders) and a fourinarow 02/27/10 05:03:49 PM
#11   It's traded very thinly which makes me think ChartMasterpieces 02/27/10 04:13:36 PM
#10   I like the look of this stock and fourinarow 02/27/10 03:42:21 PM
#9   Han wants to buy up the remaining common Cecil Bob 01/25/10 11:20:46 PM
#8   I'll do it Bob Stocks 05/22/09 03:37:45 PM
#7   No mod here eh? Bob Stocks 05/22/09 03:37:36 PM
#6   Nice numbers came out Bob Stocks 05/22/09 03:33:32 PM
#5   Got me a starter position in the .50s Bob Stocks 05/22/09 03:33:20 PM
#4   whats the share structure here guys? adamp 05/16/09 04:34:04 PM
#3   I agree, a truly profitable company StockLegend 05/15/08 12:16:43 PM
#2   Thank you for starting this board. Catawbakid 05/15/08 11:35:01 AM
#1   Dragon Pharma Reports 2008 Record First Quarter Financial Results StockLegend 05/15/08 10:57:02 AM